The biotech company will receive CRI's Grace Award in recognition of their role in advancing cancer immunotherapy.
CRI will bestow its highest honors on three scientists who have made seminal contributions to the fields of immunology and cancer immunology at its 30th Annual Awards gala.
The month-long campaign celebrates achievements in the field of immuno-oncology, with fundraising and awareness-building programs for cancer immunotherapy research.
One-day, multi-distance ride through the Lower Hudson Valley’s breathtaking landscape to raise funds for CRI and increase awareness of the potential of immunotherapy to cure all cancers.
A phase 1/2 clinical trial of combination immunotherapy for advanced ovarian cancer is launched.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, 4th Floor | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
Immunotherapy tripled the median progression-free survival rate among lung cancer patients compared to those who received only chemotherapy and radiation
We introduce you to Thomas Hudson, M.D., vice president, head of oncology discovery and early development at AbbVie.